The global facial injectable market size was valued at US$ 13.9 billion in 2020. The global facial injectable market is forecast to grow to US$ 27.1 billion by 2030 by registering a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2022 to 2030. 

Factors Influencing the Market

The global facial injectable market is driven by the increasing focus of the population on physical appearance. The COVID-19 pandemic has also increased the amount of time spent on video calls, which has raised consciousness among adults towards looks. As a result, the demand for Botox treatments has increased abruptly. 

Minimally invasive surgeries are gaining substantial traction across the globe. For instance, the American Society of Plastic Surgeons (ASPS) estimates that around 17.7 million minimally invasive were performed in 2018 in the United States. Furthermore, the presence of a wide range of effective cosmetics treatments will also benefit the facial injectable market during the study period. 

High disposable income and a rising geriatric population will also drive the demand for facial injectables during the forecast period. Furthermore, the presence of wide range of well-qualified and highly-skilled healthcare professionals, including dermatologists and surgeons, will fuel the growth of the facial injectables market during the study period. 

COVID-19 Impact Analysis

The ongoing COVID-19 pandemic is positively impacting the global facial injectable market. It is owing to the rising consciousness among citizens related to looks. However, the market witnessed significant loss during the initial phase due to strict lockdown, which forced clinics to shut their doors. As governments have lifted the restriction, the demand for facial injectables is witnessed increasing again. 

Regional Analysis

North America is forecast to dominate the facial injectable market during the study period. The growth of the market is attributed to the large geriatric population in the region and rising consciousness among the citizens. 

A study by the American Society of Plastic Surgeons (ASPS) estimates that the demand for cosmetic surgery products has increased in the United States in 2018 from 2000, in which the use of Botox injections increased by 845%. 

Followed by North America, Asia-Pacific is forecast to hold another largest market for facial injectables. It is owing to the growing concerns related to physical appearance in India, China, and other developing countries. 

Competitors in the Market

Key companies profiled in the report are

• Allergan PLC
• Medytox Inc.
• Merz Pharma GmbH & Co. KGaA
• Ipsen SA
• Nestle (Nestle Skin Health)
• Suneva Medical Inc.
• Sinclair Pharma PLC
• Teoxane SA
• Other Prominent Players

Market Segmentation

The global facial injectable market segmentation focuses on Type, Application, and Region. 

By Type Outlook

• Wrinkle Relaxers
  • Botulinum Toxin
• Dermal Fillers
  • Collagen
  • Hyaluronic Acid
  • Fat Injection
  • Polylactic Acid
  • Polymethyl-methacrylate Microspheres (PMMA)
  • Calcium Hydroxylapatite
  • Other Types (Polyalkylimide etc.)

By Application Outlook

• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Other Applications

By Regional Outlook

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America